Mehalick David

CEO and President, Director, 10% OwnerCoeptis Therapeutics Holdings, Inc. (COEP) · full profile →Form 4 · filed Jan 9, 2024
Net Buying
Open-Market Buys
$17K
Open-Market Sells
$0
Net Open-Market Flow
$17K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 8, 2024Buy(P)14K$0.66$9K2.8M
Jan 8, 2024Buy(P)6K$0.67$4K2.8M
Jan 5, 2024Buy(P)5K$0.69$3K2.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-24-000159) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about COEP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001683168-24-000159"
Ask your agent
Use Arkolith to summarize insider buying and selling at Coeptis Therapeutics Holdings, Inc.
over the last 90 days and cite the filings.